0001209191-19-005355.txt : 20190125
0001209191-19-005355.hdr.sgml : 20190125
20190125164010
ACCESSION NUMBER: 0001209191-19-005355
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190123
FILED AS OF DATE: 20190125
DATE AS OF CHANGE: 20190125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Martell Robert
CENTRAL INDEX KEY: 0001529922
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30347
FILM NUMBER: 19542979
MAIL ADDRESS:
STREET 1: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CURIS INC
CENTRAL INDEX KEY: 0001108205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043505116
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-503-6500
MAIL ADDRESS:
STREET 1: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-23
0
0001108205
CURIS INC
CRIS
0001529922
Martell Robert
4 MAGUIRE ROAD
LEXINGTON
MA
02421
0
1
0
0
Head of Research & Development
Common Stock
2019-01-23
4
F
0
8473
1.07
D
28527
D
Common Stock
2019-01-23
4
S
0
5500
1.0728
D
23027
D
Shares were withheld by the Company to satisfy minimum statutory withholding requirements related to a vesting of a service-based restricted stock award granted on January 22, 2018.
On May 29, 2018, the Company effected a 1-for-5 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
This transaction was effected pursuant to a Rule 10b5-1 trading plan to cover tax obligations.
The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $1.02 to $1.09, inclusive. The reporting person undertakes to provide to Curis, Inc., any security holder of Curis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth on this Form 4.
William Steinkrauss, attorney-in-fact
2019-01-25